- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02412124
Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers
Quality of Life Outcomes From a Peer-to-Peer Support Program for Women With Gynecologic Cancer
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
PRIMARY OBJECTIVES:
I. To test the feasibility and acceptability of a Woman-to-Woman (W2W) program for patients with gynecologic cancer at City of Hope (COH). Address the following descriptive research questions: were patients, mentors, and patients' family caregivers satisfied with the timing, format, and content of the program? Did the program benefit patients, mentors, and patients' family caregivers?
OUTLINE:
Patients participate in the W2W program for which they are matched with a trained mentor and followed throughout treatment by phone, email, and/or in person.
After completion of study, patients are followed up at 6 and 12 months.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
California
-
Duarte, California, Vereinigte Staaten, 91010
- City of Hope Medical Center
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- PATIENT PARTICIPANTS
- Patients with newly diagnosed or recurrent gynecologic cancer (ovarian, uterine, cervical, vaginal, vulvar) actively undergoing treatment (chemotherapy, surgery, or radiation therapy) at COH (including Duarte and South Pasadena campuses)
- English-speaking patients
- PEER MENTORS
- Peer mentors will be past gynecologic cancer patients not currently undergoing treatment for their cancer, and considered without evidence of disease
- Over age 18
- PEER MENTORS: English-speaking patients
- This study is open to patients of all races and ethnicities
Exclusion Criteria:
- PEER MENTORS:
- Major psychiatric disease
- Currently undergoing treatment for active gynecologic cancer
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Supportive care (W2W program)
Patients participate in the W2W program for which they are matched with a trained mentor and followed throughout treatment by phone, email, and/or in person.
|
Complete W2W mentoring program
Andere Namen:
Complete the FACT-G
Andere Namen:
Complete the W2W Patient Survey
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in quality of life benefits for patients, as assessed by the FACT-G
Zeitfenster: Baseline to up to 12 months
|
Changes from baseline will be tested using paired t-tests.
Data will be summarized using descriptive statistics, including means for normally distributed continuous data, medians for non-normally distributed continuous data or proportions for categorical data.
Established instruments will be scored according to standard instructions, and appropriate descriptive statistics computed.
Written comments from all open ended questions analyzed using content analysis methods.
|
Baseline to up to 12 months
|
Satisfaction of patients with the timing, content, and format of the program, as assessed by the W2W Patient Survey
Zeitfenster: Up to 12 months
|
Changes from baseline will be tested using paired t-tests.
Descriptive statistics on participants' satisfaction with the timing, content, and format of the intervention will be presented through summary statistics of data from the satisfaction tools.
Data will be summarized using descriptive statistics, including means for normally distributed continuous data, medians for non-normally distributed continuous data or proportions for categorical data.
|
Up to 12 months
|
Satisfaction of mentors with the timing, content, and format of the program, as assessed by the W2W Volunteer/Mentor Survey
Zeitfenster: Up to 12 months
|
Descriptive statistics on participants' satisfaction with the timing, content, and format of the intervention will be presented through summary statistics of data from the satisfaction tools.
|
Up to 12 months
|
Satisfaction of patients' family caregivers with the timing, content, and format of the program
Zeitfenster: Up to 12 months
|
Changes from baseline will be tested using paired t-tests.
Descriptive statistics on participants' satisfaction with the timing, content, and format of the intervention will be presented through summary statistics of data from the satisfaction tools.
|
Up to 12 months
|
Benefits for patients' family caregivers after participating in the program, as assessed by the Modified Caregiver Strain Index
Zeitfenster: Up to 12 months
|
Data will be summarized using descriptive statistics, including means for normally distributed continuous data, medians for non-normally distributed continuous data or proportions for categorical data.
Established instruments will be scored according to standard instructions, and appropriate descriptive statistics computed.
Written comments from all open ended questions analyzed using content analysis methods.
|
Up to 12 months
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Thanh Dellinger, MD, City of Hope Medical Center
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 14359 (Andere Kennung: City of Hope Medical Center)
- NCI-2015-00467 (Registrierungskennung: CTRP (Clinical Trial Reporting Program))
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Zervixkarzinom
-
Tanta UniversityNoch keine RekrutierungSchilddrüsenchirurgie | Verbesserte Wiederherstellung | Bilateraler ultraschallgeführter oberflächlicher Plexus-Cervical-Block
-
McMaster UniversitySt. Joseph's Healthcare Hamilton; Hamilton Health Sciences CorporationUnbekanntInvasiver Brustkrebs | Duktales Carcinoma in situ der BrustKanada
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Abgeschlossen
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)BeendetBrustkrebsVereinigte Staaten
-
University of AarhusUnbekanntCarcinoma in situ des GebärmutterhalsesDänemark
-
Khon Kaen UniversityBeendetHumane Papillomavirus-Clearance nach 12 MonatenThailand
-
University of Southern CaliforniaBeendetBrustkrebsVereinigte Staaten
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...Aktiv, nicht rekrutierendDuktales Carcinoma in situ der BrustVereinigte Staaten
-
Endo PharmaceuticalsAbgeschlossen
-
Orthofix Inc.AbgeschlossenDegenerative Bandscheibenerkrankungen | Vertebral Cervical Fusion SyndromeVereinigte Staaten
Klinische Studien zur Supportive Care
-
University of HaifaAktiv, nicht rekrutierend
-
Chunrui LiNanjing IASO Biotechnology Co., LtdRekrutierungPlasmazell-Leukämie | Rezidiviertes/refraktäres multiples MyelomChina
-
Zhejiang UniversityCarbiogene Therapeutics Co. Ltd.Noch keine RekrutierungFortgeschrittenes hepatozelluläres KarzinomChina
-
Nexcella Inc.Noch keine RekrutierungLeichtketten (AL)-AmyloidoseVereinigte Staaten
-
Second Affiliated Hospital, School of Medicine,...RekrutierungRezidiviertes und refraktäres B-Zell-LymphomChina
-
Second Affiliated Hospital, School of Medicine,...Rekrutierung
-
Hebei Senlang Biotechnology Inc., Ltd.RekrutierungLymphom | Multiples Myelom | Akute lymphatische LeukämieChina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy,...ZurückgezogenAkute lymphatische Leukämie | Non-Hodgkin-LymphomVereinigte Staaten
-
Nanjing IASO Biotechnology Co., Ltd.Ruijin HospitalRekrutierungPlasmazell-Leukämie | Rezidiviertes/refraktäres multiples MyelomChina
-
University of California, San FranciscoZurückgezogenLymphom | Leukämie | Plasmazelldyskrasie